Covid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010)
Alvino Bisecco,Federica Matrone,Marco Alfonso Narduc Capobianco,Giovanna De Luca,Massimo Filippi,Franco Granella,Giacomo Lus,Girolama Alessandra Marfia,Massimiliano Mirabella,Francesco Patti,Maria Trojano, Agnese Mascolo,Massimiliano Copetti,Gioacchino Tedeschi,Antonio Gallo Neurology（2024）
AI 理解论文
溯源树
样例
